CBAI projects it will become cash flow positive for the first time in its history
- By continuing to de-lever its balance sheet through debt reductions and
- By expansion through internal growth coupled with strategic acquisitions
OVERVIEW
- Emerging leader in an emerging market
- Umbilical cord blood collection, a non-controversial and valuable source of stem cells